Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.

Saved in:
Bibliographic Details
Title: Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.
Authors: Bergman DR; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States., Wang Y; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States., Trujillo E; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Fernald AA; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Li L; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Pearson AT; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Sweis RF; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States., Jackson TL; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States.
Source: Frontiers in immunology [Front Immunol] 2024 Mar 07; Vol. 15, pp. 1358019. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38515743
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bergman+DR%22">Bergman DR</searchLink>; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Trujillo+E%22">Trujillo E</searchLink>; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Fernald+AA%22">Fernald AA</searchLink>; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Pearson+AT%22">Pearson AT</searchLink>; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Sweis+RF%22">Sweis RF</searchLink>; Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Jackson+TL%22">Jackson TL</searchLink>; Department of Mathematics, University of Michigan, Ann Arbor, MI, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Mar 07; Vol. 15, pp. 1358019. <i>Date of Electronic Publication: </i>2024 Mar 07 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38515743
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1358019
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1358019
    Titles:
      – TitleFull: Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bergman DR
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Trujillo E
      – PersonEntity:
          Name:
            NameFull: Fernald AA
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Pearson AT
      – PersonEntity:
          Name:
            NameFull: Sweis RF
      – PersonEntity:
          Name:
            NameFull: Jackson TL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 03
              Text: 2024 Mar 07
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1